Key facts
- This page summarizes Ian Shakil's Form 4 filing for Augmedix, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Apr 2024, 21:07.
Ian Shakil - 15 Apr 2024 Form 4 Insider Report for Augmedix, Inc.
- Reporting relationship
- CHIEF STRATEGY OFFICER, Director
- Issuer ticker
- N/A
- Reported as of
- 15 Apr 2024
- Net transaction value
- -$1,470
- SEC form
- 4
- Accepted by SEC
- 16 Apr 2024, 21:07:21 UTC
- Prior SEC filing
- 15 Apr 2024
- Next SEC filing
- 19 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Holvick, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ian Shakil filed Form 4 for Augmedix, Inc. on 16 Apr 2024.
Change
- Previous filing in this sequence was filed on 15 Apr 2024.
- Current net transaction value: -$1,470.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUGX
transaction
Common Stock
Options Exercise
- Transaction value
- $430
- Shares
- +500
- Change %
- +17%
- Price
- $0.8600
- Shares after
- 3,500
- Date
- 15 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
AUGX
transaction
Common Stock
Sale
- Transaction value
- $1,900
- Shares
- -500
- Change %
- -14%
- Price
- $3.80
- Shares after
- 3,000
- Date
- 15 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUGX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -500
- Change %
- -0.11%
- Price
- $0.000000
- Shares after
- 455,949
- Date
- 15 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $0.8600
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
This transaction was executed pursuant to a Rule 10b5-1 trading plan.
Footnote F2
Fully vested.